Patients receiving etoposide and cisplatin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Cell Line, Tumor Tumor Cells, Cultured HL-60 Cells Cell Line Kidney

Organisms1

Diseases44

Carcinoma, Small Cell Lung Neoplasms Leukopenia Germinoma Ovarian Neoplasms Testicular Neoplasms Neoplasms, Germ Cell and Embryonal Neutropenia Carcinoma, Non-Small-Cell Lung Vomiting Hematologic Diseases Thrombocytopenia Head and Neck Neoplasms Carcinoma, Squamous Cell Nausea Neoplasms Neoplasm Recurrence, Local Adenocarcinoma Hodgkin Disease Small Cell Lung Carcinoma Lymphoma, Non-Hodgkin Alopecia Stomach Neoplasms Retroperitoneal Neoplasms Bone Marrow Diseases Seminoma Neuroblastoma Carcinoma Osteosarcoma Dysgerminoma Mediastinal Neoplasms Esophageal Neoplasms Neoplasm Metastasis Mesothelioma Bone Neoplasms Neoplasms, Unknown Primary Brain Neoplasms Recurrence Pleural Neoplasms Urologic Neoplasms Leukemia Peritoneal Neoplasms Disease Progression Stomatitis

Chemicals and Drugs75

Etoposide Cisplatin Antineoplastic Agents Antineoplastic Agents, Phytogenic Ifosfamide Doxorubicin Carboplatin Topoisomerase II Inhibitors Platinum Vincristine Podophyllotoxin Cyclophosphamide DNA Topoisomerases, Type II Bleomycin Vinblastine Paclitaxel Camptothecin Amsacrine Deoxycytidine Fluorouracil DNA Adducts Cytarabine Teniposide Carmustine Vindesine Nucleic Acid Synthesis Inhibitors Taxoids Topoisomerase Inhibitors Mitomycin Mitoxantrone Methotrexate Topoisomerase I Inhibitors Granulocyte Colony-Stimulating Factor Epirubicin Tumor Suppressor Protein p53 Melphalan Caspases P-Glycoprotein Proto-Oncogene Proteins c-bcl-2 Antineoplastic Agents, Alkylating Organophosphorus Compounds Topotecan Procarbazine Oxonic Acid Prednisone Antibiotics, Antineoplastic DNA-Binding Proteins Mesna Caspase 3 Razoxane Levoleucovorin Amifostine Tegafur Antimetabolites, Antineoplastic Enzyme Inhibitors DNA Topoisomerases, Type I Daunorubicin DNA Multidrug Resistance-Associated Proteins Radiation-Sensitizing Agents Thiosulfates Antiemetics Dexamethasone Dacarbazine Mitomycins Poly(ADP-ribose) Polymerases Mitotane Glutathione Leucovorin Neoplasm Proteins Prodrugs Ondansetron bcl-2-Associated X Protein Dactinomycin RNA, Small Interfering

Analytical, Diagnostic and Therapeutic Techniques and Equipment35

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Combined Modality Therapy Treatment Outcome Infusions, Intravenous Survival Analysis Disease-Free Survival Drug Screening Assays, Antitumor Survival Rate Drug Evaluation Remission Induction Salvage Therapy Neoplasm Staging Administration, Oral Transplantation, Autologous Chemotherapy, Adjuvant Maximum Tolerated Dose Prognosis Inhibitory Concentration 50 Radiotherapy Dosage Radiotherapy, Adjuvant Feasibility Studies Dose Fractionation Induction Chemotherapy Hematopoietic Stem Cell Transplantation Xenograft Model Antitumor Assays Neoadjuvant Therapy Tumor Stem Cell Assay Follow-Up Studies Blotting, Western Prospective Studies Transfection Actuarial Analysis Kaplan-Meier Estimate Infusions, Intra-Arterial

Phenomena and Processes20

Drug Resistance, Neoplasm Apoptosis Dose-Response Relationship, Drug DNA Damage Drug Synergism DNA Adducts Cell Survival Drug Resistance Drug Resistance, Multiple DNA Repair Time Factors Maximum Tolerated Dose Cell Cycle Inhibitory Concentration 50 Gene Expression Regulation, Neoplastic Drug Interactions Cell Proliferation DNA Fragmentation Transfection Cell Death

Information Science1

Health Care9

Treatment Outcome Survival Analysis Disease-Free Survival Survival Rate Feasibility Studies Follow-Up Studies Prospective Studies Actuarial Analysis Kaplan-Meier Estimate

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Etoposide Cisplatin Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Antineoplastic Agents, Phytogenic Ifosfamide Drug Administration Schedule Carcinoma, Small Cell Doxorubicin Lung Neoplasms Carboplatin Topoisomerase II Inhibitors Combined Modality Therapy Drug Resistance, Neoplasm Platinum Vincristine Podophyllotoxin Cyclophosphamide DNA Topoisomerases, Type II Bleomycin Vinblastine Treatment Outcome Paclitaxel Leukopenia Apoptosis Germinoma Infusions, Intravenous Ovarian Neoplasms Testicular Neoplasms Survival Analysis Cell Line, Tumor Disease-Free Survival Tumor Cells, Cultured Camptothecin Dose-Response Relationship, Drug DNA Damage Neoplasms, Germ Cell and Embryonal Drug Screening Assays, Antitumor Amsacrine Deoxycytidine Survival Rate Fluorouracil Drug Synergism Neutropenia DNA Adducts Cytarabine Drug Evaluation Carcinoma, Non-Small-Cell Lung Remission Induction Cell Survival Vomiting Teniposide Drug Resistance Hematologic Diseases Thrombocytopenia Carmustine Head and Neck Neoplasms Salvage Therapy Carcinoma, Squamous Cell Neoplasm Staging Vindesine Nucleic Acid Synthesis Inhibitors Nausea Taxoids Administration, Oral Topoisomerase Inhibitors Transplantation, Autologous Neoplasms Neoplasm Recurrence, Local Mitomycin Mitoxantrone Adenocarcinoma Methotrexate Topoisomerase I Inhibitors Drug Resistance, Multiple Granulocyte Colony-Stimulating Factor Epirubicin Tumor Suppressor Protein p53 Hodgkin Disease Melphalan Caspases DNA Repair P-Glycoprotein Small Cell Lung Carcinoma Lymphoma, Non-Hodgkin Alopecia Stomach Neoplasms Retroperitoneal Neoplasms Time Factors Chemotherapy, Adjuvant Maximum Tolerated Dose Cell Cycle Proto-Oncogene Proteins c-bcl-2 Antineoplastic Agents, Alkylating Prognosis Organophosphorus Compounds Bone Marrow Diseases Topotecan Procarbazine Oxonic Acid

No FAQ available that match "patients receiving etoposide and cisplatin"